MG-S-2525

DB18063InvestigationalSmall molecule

MG-S-2525: Overview.

Mechanism: Pharmacologically active on Mitogen-activated protein kinase kinase kinase 19
Curator reviewed
Formula / weight: C₂₃H₂₈N₆O₃ · 436.516 g/mol (avg)
Also known as: 5-(3,5-Dimethyl-4-hydroxybenzylamino)-3-(4-morpholin-4-yl-phenylamino)-1H-pyrazole-4-carboxylic acid amide
Code names: MG-S-2525

Resolves to

Compound

Structure

InChIKeyAWTYZRBONKSIES-UHFFFAOYSA-NSMILESCC1=CC(CNC2=C(C(N)=O)C(NC3=CC=C(C=C3)N3CCOCC3)=NN2)=CC(C)=C1O

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with MG-S-2525, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.